Literature DB >> 6122768

Epstein-Barr-virus-specific T-cell memory in renal-allograft recipients under long-term immunosuppression.

J S Gaston, A B Rickinson, M A Epstein.   

Abstract

The level of long-term responsiveness of cytotoxic T cells to Epstein-Barr (EB) virus has been measured in peripheral-blood mononuclear-cell cultures from symptom-free renal-allograft recipients under conventional immunosuppression. 8 of 22 patients showed a profoundly impaired responsiveness when compared with health control donors. The allograft recipients as a group showed raised antibody titres to EB-virus capsid and early antigens, but within the group there was no clear relation between these antibody titres and the level of EB-virus-specific cytotoxic-T-cell function. These findings are particularly relevant to the pathogenesis of the malignant lymphomas to which renal-allograft recipients are unusually susceptible, in view of the evidence implicating EB virus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6122768     DOI: 10.1016/s0140-6736(82)91930-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

Review 1.  Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.

Authors:  M A Epstein; A J Morgan
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

2.  Disturbance of the Epstein-Barr virus-host balance in rheumatoid arthritis patients: a quantitative study.

Authors:  Q Y Yao; A B Rickinson; J S Gaston; M A Epstein
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

3.  Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice.

Authors:  M J Cannon; P Pisa; R I Fox; N R Cooper
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.

Authors:  R J Murray; D Wang; L S Young; F Wang; M Rowe; E Kieff; A B Rickinson
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

5.  In vitro analysis of Epstein-Barr virus: host balance in patients with acute Plasmodium falciparum malaria. I. Defective T-cell control.

Authors:  D E Gunapala; C A Facer; R Davidson; W R Weir
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

6.  Heterogeneity of immune defects in three children with a chronic active Epstein-Barr virus infection.

Authors:  W Kuis; J J Roord; B J Zegers; A B Rickinson; J G Kapsenberg; H The; J W Stoop
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

7.  The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children.

Authors:  M Ho; R Jaffe; G Miller; M K Breinig; J S Dummer; L Makowka; R W Atchison; F Karrer; M A Nalesnik; T E Starzl
Journal:  Transplantation       Date:  1988-04       Impact factor: 4.939

8.  Epstein-Barr virus-specific cytotoxic T cell responses in rheumatoid arthritis patients.

Authors:  J S Gaston; A B Rickinson; M A Epstein
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

9.  The abnormal cytotoxic T cell response to Epstein-Barr virus in rheumatoid arthritis is correlated with disease activity and occurs in other arthropathies.

Authors:  J S Gaston; A B Rickinson; Q Y Yao; M A Epstein
Journal:  Ann Rheum Dis       Date:  1986-11       Impact factor: 19.103

10.  Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin.

Authors:  A Chadburn; N Suciu-Foca; E Cesarman; E Reed; R E Michler; D M Knowles
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.